Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsRaw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outlook Therapeutics (OTLK) Work In Process (2025)

Historic Work In Process for Outlook Therapeutics (OTLK) over the last 1 years, with Q4 2025 value amounting to $1.1 million.

  • Outlook Therapeutics' Work In Process changed N/A to $1.1 million in Q4 2025 from the same period last year, while for Dec 2025 it was $1.1 million, marking a year-over-year change of. This contributed to the annual value of $958539.0 for FY2025, which is N/A changed from last year.
  • According to the latest figures from Q4 2025, Outlook Therapeutics' Work In Process is $1.1 million.
  • Outlook Therapeutics' 5-year Work In Process high stood at $3.7 million for Q2 2025, and its period low was $271190.0 during Q1 2025.